Nordic Life Science Days 2016

The Nordic region is proud to host some of the world’s most innovative biotech, medtech and pharma companies. It also has the 12th strongest economy, making it the perfect place to invest. Set in the idyllic city of Stockholm, the conference offers conference sessions, panel discussions, company presentations, exhibition, face-to-face meetings and unique receptions, providing so many opportunities to network with peers, potential partners and investors.

Who will be speaking?

We've gathered Life Science experts from all over the world and the industry to put together the best NLSDays 2016 program! Here is a sampling of the speakers you will see in Stockholm.

You can have an overview of the program here.

Dr. Gary Gordon, Vice President, Oncology Development, AbbVie

Dr. Johan Liwing, Director Market Access RWE Partnerships, Global Commercial Strategy Organisation, Janssen - J&J Innovation
Dr. Francisco Rausa, Sr. Principal Research Scientist, Future Therapeutics and Technology, AbbVie
Dr. Tobias Sjöblom, Associate Professor at Uppsala University, U-CAN and Uppsala University

Dr. Patrick Larcier, Vice-President Drug Development & Vigilance Operations, Voisin Consulting

Prof. Carl Borrebaeck, Centre Director CREATE Health, Lund University

Dr. Klaus Mendla, Global Head, CNS Business Development and Licensing bei Boehringer Ingelheim
Dr. Christer Nordstedt, Vice President and Head CNS Research and Clinical Investigation at Eli Lilly and Company

Prof. Inge Marie Svane, Director Center for Cancer Immune Therapy – CCIT Dept. of Oncology and Hematology Herlev Hospital, University of Copenhagen
Dr. Khatereh Ahmadi, Executive Director, Oncology Search and Evaluation Lead, European Hub, MSD
Dr. Øyvind Arnesen, CEO Ultimovacs
Prof. Karl Johan Malmberg, Oslo University Hospital and Karolinska Institute

Dr. Miro Venturi, Global Head Diagnostics Biomarkers, Roche